Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avient (AVNT) Other financing activities (2016 - 2025)

Historic Other financing activities for Avient (AVNT) over the last 13 years, with Q3 2025 value amounting to $10.7 million.

  • Avient's Other financing activities fell 1705.43% to $10.7 million in Q3 2025 from the same period last year, while for Dec 2025 it was $3.9 million, marking a year-over-year decrease of 5937.5%. This contributed to the annual value of $3.9 million for FY2025, which is 5937.5% down from last year.
  • Per Avient's latest filing, its Other financing activities stood at $10.7 million for Q3 2025, which was down 1705.43% from -$3.2 million recorded in Q2 2025.
  • Over the past 5 years, Avient's Other financing activities peaked at $53.4 million during Q3 2022, and registered a low of -$3.9 million during Q1 2022.
  • For the 5-year period, Avient's Other financing activities averaged around $5.1 million, with its median value being -$1.6 million (2024).
  • Its Other financing activities has fluctuated over the past 5 years, first tumbled by 165000.0% in 2021, then soared by 162571.43% in 2022.
  • Avient's Other financing activities (Quarter) stood at -$3.5 million in 2021, then surged by 1625.71% to $53.4 million in 2022, then crashed by 91.39% to $4.6 million in 2023, then soared by 180.43% to $12.9 million in 2024, then decreased by 17.05% to $10.7 million in 2025.
  • Its last three reported values are $10.7 million in Q3 2025, -$3.2 million for Q2 2025, and -$3.6 million during Q1 2025.